TERN Q4 2025 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage ALXO Q1 2026 Earnings EPS Beat Highlights Controlled Cash Burn No Revenue Yet LCID Q1 2026 Earnings WiderthanExpected Loss Sends Mixed Signals as Stock Rises Modestly Tvardi Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as pipeline advances Castle Biosciences Q1 2026 Earnings EPS Beat Slightly Narrower Loss Stock Rises 26 Analyst Chandan Taparia Highlights Three Stocks for Potential Focus on May 22 2026 REAX Q1 2026 Earnings EPS Beats Estimates as Loss Narrows